# Use of the Hansen Medical System in Patients With Paroxysmal Atrial Fibrillation

Study · id `cardio:ct-nct01122173` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01122173](<https://clinicaltrials.gov/study/NCT01122173>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01122173

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 150 participants.

## Technical summary

Registry record NCT01122173. Allocation not applicable; no masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2017-04 (actual). Results posted on 2018-09-11.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT01122173, source copy `cardio:ctgov-nct01122173-2018-09-11`, retrieved 2026-10-26)
- Start date: 2013-07 (registry gives no type) (ClinicalTrials.gov record NCT01122173, source copy `cardio:ctgov-nct01122173-2018-09-11`, retrieved 2026-10-26)
- Primary completion: 2017-04 (actual) (ClinicalTrials.gov record NCT01122173, source copy `cardio:ctgov-nct01122173-2018-09-11`, retrieved 2026-10-26)
- Completion: 2017-04 (actual) (ClinicalTrials.gov record NCT01122173, source copy `cardio:ctgov-nct01122173-2018-09-11`, retrieved 2026-10-26)
- Results first posted: 2018-09-11 (ClinicalTrials.gov record NCT01122173, source copy `cardio:ctgov-nct01122173-2018-09-11`, retrieved 2026-10-26)
- Countries: United States; Czechia; Denmark; Spain; United Kingdom (ClinicalTrials.gov record NCT01122173, source copy `cardio:ctgov-nct01122173-2018-09-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01122173-2018-09-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Use of the Hansen Medical System in Patients With Paroxysmal Atrial Fibrillation
- Condition: Paroxysmal Atrial Fibrillation
- Intervention (Device): Ablation
- Lead sponsor: Hansen Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: f48fae48fb1f9575f0b26baf62a3efdb19190739ac4adf7eef918fe311045308
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
